CD8+ T cells accumulate in atherosclerotic plaques. Researchers identify a crucial signaling pathway -- with therapeutic potential.
Background and aims In the primary prevention setting, low-dose aspirin reduces major vascular events (MVEs) by approximately ...
The U.S. atherosclerosis treatment market is driven by a high prevalence of cardiovascular diseases, pharmaceutical advancements, an aging population, lifestyle risks, and government health ...
Coronary artery disease (CAD), or the narrowing of the coronary arteries, is the leading cause of morbidity and mortality throughout the world. Atherosclerosis, or the buildup of plaque in the ...
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) and the Germans Trias i Pujol Research Institute (IGTP ...
1d
MedPage Today on MSNCoronary Plaques Reined in With Coronary Calcium Scans in the PictureFor select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...
In other words, all atherosclerotic plaques ... why isn’t everyone who is at high risk for heart disease doing it? The simple answer is that it requires commitment, dedication, discipline ...
A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...
The study found that atherosclerosis was present in nearly one-third of the study participants, indicating a high prevalence of heart disease. The cardiovascular disease risk factors examined are ...
3d
News Medical on MSNIntermittent fasting cuts heart attack risk by preventing dangerous blood clotsIntermittent fasting may reduce the risk of blood clots and cardiovascular disease by inhibiting platelet activation.
9d
News-Medical.Net on MSNResearchers discover key signaling pathway involved in atherosclerotic plaquesCD8+ T cells accumulate in atherosclerotic plaques. LMU researchers identify a crucial signaling pathway - with therapeutic potential.
1d
GlobalData on MSNShockwave Medical launches IVL catheter in US for peripheral artery diseaseJohnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results